Arcadia Biosciences Inc expected to post a loss of $4.80 a share - Earnings Preview

Arcadia Biosciences

08/08/2023 23:15

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected
to show a
fall in quarterly revenue when it reports  results on August
10. 
    * The Davis California-based  company is expected to report 
a
52.8% decrease in revenue to $1.82 million from $3.86 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Arcadia Biosciences
Inc
is for a loss of $4.80 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $17.5​, above​ its last closing price
of $4.61. ​​​

This summary was machine generated August 8 at 22:15 GMT.  All
figures in US dollars  unless otherwise stated